Cheviot Value Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$30K Hold
200
﹤0.01% 216
2025
Q1
$21.3K Buy
+200
New +$21.3K ﹤0.01% 236